Want to see DE:M3V full AI Analyst Report?

MeVis Medical Solutions (M3V) Price & Analysis

3 Followers

M3V Stock Chart & Stats

€24.20

€0.00(0.00%)

At close: Jul 27 4:00 PM EDT

€24.20

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€22.20 - €26.80

Previous CloseN/A

Volume1.00

Average Volume (3M)99.00

Market Cap

€42.95M

Enterprise Value€39.30M

Total Cash (Recent Filing)€3.65M

Total Debt (Recent Filing)€0.00

Price to Earnings (P/E)19.5

Beta0.22

Next Earnings

Jan 28, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.03%

Share Statistics

EPS (TTM)0.55

Shares Outstanding1,820,000

10 Day Avg. Volume191

30 Day Avg. Volume99

Financial Highlights & Ratios

PEG Ratio-0.46

Price to Book (P/B)2.53

Price to Sales (P/S)2.81

P/FCF Ratio12.07

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance SheetZero total debt materially reduces financial risk and preserves strategic optionality. A debt-free capital structure supports sustained dividend policy, funds M&A or R&D from internal resources, and lowers bankruptcy risk, providing durable financial flexibility over 2–6 months and beyond.

High And Sustainable Gross MarginsConsistently high gross and operating margins reflect a scalable software business with pricing power and low incremental costs. Such structural margins support long-term cash generation, fund product development, and create a durable moat versus lower-margin competitors.

Strong Cash Generation Track RecordFree cash flow that generally tracks earnings indicates the business converts profits into spendable cash, supporting dividends and reinvestment without reliance on external financing. This cash-generation capacity bolsters financial resilience and funding flexibility.

Bears Say

Multi-year Revenue DeclineThree consecutive years of shrinking revenue signal weakening demand or competitive pressure, reducing growth runway. Persistent top-line contraction can erode scale advantages, strain future margin recovery, and limit ability to invest in product and market expansion over the medium term.

Sharply Reduced Net Margins Vs 2022 PeakA steep fall in net margins halves profitability relative to the 2022 peak, indicating rising costs, pricing pressure, or structural mix shifts. Sustained margin erosion diminishes cash available for investment and dividends, and raises questions about long-term operating leverage.

Volatile Cash-flow ConversionWide swings in cash conversion impair predictability of internal funding and make capital allocation harder. Volatile FCF undermines confidence in earnings quality, may force reliance on retained earnings for investments, and complicates sustaining dividends or growth investments.

M3V FAQ

What was MeVis Medical Solutions AG’s price range in the past 12 months?

MeVis Medical Solutions AG lowest stock price was €22.20 and its highest was €26.80 in the past 12 months.

What is MeVis Medical Solutions AG’s market cap?

MeVis Medical Solutions AG’s market cap is €42.95M.

When is MeVis Medical Solutions AG’s upcoming earnings report date?

MeVis Medical Solutions AG’s upcoming earnings report date is Jan 28, 2027 which is in 168 days.

How were MeVis Medical Solutions AG’s earnings last quarter?

MeVis Medical Solutions AG released its earnings results on May 21, 2026. The company reported €0.342 earnings per share for the quarter, beating the consensus estimate of N/A by €0.342.

Is MeVis Medical Solutions AG overvalued?

According to Wall Street analysts MeVis Medical Solutions AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MeVis Medical Solutions AG pay dividends?

MeVis Medical Solutions AG pays a Annually dividend of €0.95 which represents an annual dividend yield of 4.03%. See more information on MeVis Medical Solutions AG dividends here

What is MeVis Medical Solutions AG’s EPS estimate?

MeVis Medical Solutions AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MeVis Medical Solutions AG have?

MeVis Medical Solutions AG has 1,820,000 shares outstanding.

What happened to MeVis Medical Solutions AG’s price movement after its last earnings report?

MeVis Medical Solutions AG reported an EPS of €0.342 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of MeVis Medical Solutions AG?

Currently, no hedge funds are holding shares in DE:M3V

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MeVis Medical Solutions Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

4.03%

Trailing 12-Months

Asset Growth

-1.86%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

MeVis Medical Solutions AG

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sonography; as well as provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. In addition, the company provides three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians; and internet-based special applications in teleradiology. The company was founded in 1997 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Corporation.